Genetic Analysis: Launch of GA-map® Discovery – A microbiome profiling offering for Research Customers
GA-map new product Discovery launch
Genetic Analysis: Development project initiated for a new companion diagnostic test
OSLO, NORWAY – 12 October 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that the Company has successfully completed a pilot project and initiated a development…
Half-year report January–June 2023
OSLO, NORWAY, August 30, 2023 – Genetic Analysis AS (“GA” or “the Company”) hereby publishes the half-year report for the second quarter and first six months of 2023. The half-year…
Genetic Analysis AS ramps up its market presence for the GA-map® microbiome testing in the US
OSLO, NORWAY – August 25, 2023: Microbiome diagnostics specialist, Genetic Analysis AS (“GA”) has through its distributor Eagle Biosciences Inc, entered an agreement with an undisclosed partner, a high-volume lab…
New publication shows the benefits of the GA-map® testing platform in Diabetes Type 2
OSLO, NORWAY – 23 August 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that a scientific article has recently been published in the medical journal BMC…
Genetic Analysis receives patent approval in South Africa
OSLO, NORWAY – June 29, 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that the Company has been awarded a patent (2017/06307) by the South African…
Genetic Analysis AS enters an agreement with ELTA90 Group to distribute and launch GA-map® technology in the Balkan region
OSLO, NORWAY – 8 June 2023: Molecular diagnostics specialist, Genetic Analysis AS (“GA”) has entered a distribution agreement with ELTA90 Group (“ELTA90”), a Sofia based fast growing distributor of Laboratory…
Genetic Analysis AS: Mandatory notification of trade – Primary Insiders
OSLO, NORWAY – 26 May 2023: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management has bought GEAN-shares. Ronny Hermansen, CEO of Genetic Analysis AS,…
Interim report January–March 2023
OSLO, NORWAY, May 25, 2023 – Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim report for the first quarter of 2023. The interim report is available as…
Minutes from the Annual General Meeting 2023 in Genetic Analysis AS
Oslo, Norway, May 11, 2023 – Genetic Analysis AS (the “Company”, Ticker: GEAN) held its Annual General Meeting today, May 11th, at 15:00 hours (CET) on the Company’s premises in…
Notice of Annual General Meeting 2023
Notice is hereby served that the annual general meeting of Genetic Analysis AS (the “Company”) will be held on Thursday 11 May 2023 at 15:00 hours in the Company’s premises…
Publication of Genetic Analysis’ 2022 Annual Report
(Oslo, April 20, 2023) Genetic Analysis AS (“GA” or “the Company”) hereby publishes the Annual Report for the financial year of 2022. The Annual Report is available as an attached…
Genetic Analysis presents at Mangold Insight’s Investor Day
OSLO, NORWAY, March 17, 2023 – Genetic Analysis (“GA”) will attend Mangold Insight’s Investor Day next Wednesday, 22 March 2023. Ronny Hermansen, CEO, and Kari Furu, Head of Product and…
Year-end report January – December 2022
OSLO, NORWAY, 17 February 2023 – Genetic Analysis AS (“GA” or “the Company”) hereby publishes the year-end report for the period 1 January – December 31, 2022. The year-end report…
Genetic Analysis strengthens and future-proofs the organization
OSLO, NORWAY, January 31, 2023 – Molecular diagnostics specialist, Genetic Analysis AS (“GA”) is happy to announce that GA is strengthening and future-proofing the organization within business development, sales, and…